Moss Adams Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Moss Adams Wealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Sell	5,128 -8	-0.2%	-$1.57K	0.07%	88
2026 Q1	$1.01M	Buy	+5,136	New	+$998K	0.07%	80
2024 Q3	–	Sell	-4,855	Closed	-$665K	–	209
2024 Q2	$665K	Buy	4,855 +127	+3%	+$17.4K	0.09%	66
2024 Q1	$629K	Sell	4,728 -33	-0.7%	-$4.28K	0.1%	63
2023 Q4	$656K	Buy	4,761 +45	+1%	+$5.92K	0.14%	46
2023 Q3	$575K	Sell	4,716 -270	-5%	-$36K	0.2%	39
2023 Q2	$701K	Buy	4,986 +39	+0.8%	+$5.38K	0.23%	36
2023 Q1	$700K	Sell	4,947 -13	-0.3%	-$1.86K	0.24%	35
2022 Q4	$776K	Buy	+4,960	New	+$713K	0.39%	41

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Moss Adams Wealth Advisors's DGX Position: Q2 2026 in Review

Moss Adams Wealth Advisors reduced its Quest Diagnostics (DGX) stake by 0.16% in Q2 2026, selling an estimated $1.57K and leaving 5,128 shares worth $1.09M. The position accounts for 0.07% of the portfolio, ranked #88.

Moss Adams Wealth Advisors first reported a position in DGX in Q4 2022 and has held it in 9 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Moss Adams Wealth Advisors held 5,128 shares of Quest Diagnostics worth $1.09M as of Q2 2026.
Moss Adams Wealth Advisors sold 8 Quest Diagnostics shares in Q2 2026, an estimated $1.57K.
Quest Diagnostics made up 0.07% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #88 holding.
Moss Adams Wealth Advisors first reported a position in Quest Diagnostics in Q4 2022 and has held it in 9 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.